Package 69117-0010-2

{"route": ["ORAL"], "spl_id": "47237b45-ce93-292b-e063-6394a90a1ab5", "openfda": {"upc": ["0369117001011", "0369117001127", "0369117001110", "0369117001134"], "unii": ["G447S0T1VC"], "rxcui": ["313564", "313565"], "spl_set_id": ["f3ee4017-a4fc-475d-a49b-b39168ec5966"], "manufacturer_name": ["Yiling Pharmaceutical, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET in 1 BOTTLE (69117-0010-1)", "package_ndc": "69117-0010-1", "marketing_start_date": "20181001"}, {"sample": false, "description": "90 TABLET in 1 BOTTLE (69117-0010-2)", "package_ndc": "69117-0010-2", "marketing_start_date": "20181001"}, {"sample": false, "description": "500 TABLET in 1 BOTTLE (69117-0010-3)", "package_ndc": "69117-0010-3", "marketing_start_date": "20181001"}], "brand_name": "Valacyclovir", "product_id": "69117-0010_47237b45-ce93-292b-e063-6394a90a1ab5", "dosage_form": "TABLET", "pharm_class": ["DNA Polymerase Inhibitors [MoA]", "Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Nucleoside Analog [EXT]"], "product_ndc": "69117-0010", "generic_name": "Valacyclovir", "labeler_name": "Yiling Pharmaceutical, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Valacyclovir", "active_ingredients": [{"name": "VALACYCLOVIR HYDROCHLORIDE", "strength": "500 mg/1"}], "application_number": "ANDA209553", "marketing_category": "ANDA", "marketing_start_date": "20181001", "listing_expiration_date": "20261231"}